| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_61e2384a6ccd9c5761e5fe33edcceb54 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6018 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-549
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6911
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1271 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08 |
| filingDate |
2006-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a03acb3d9e5b2c28869e25d13b46c7ed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d822b98a9ddb29c38bd7b121258446d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92955db61755a52ac9d0dd2efff229fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98de0ef5f7a99ca1dd44222090d5c835
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f3dc218c9130ac870e02169b816e3da |
| publicationDate |
2009-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2009081284-A1 |
| titleOfInvention |
Therapeutic agent for allergy containing liposome having oligosaccharide on its surface |
| abstract |
An object of the present invention is to provide a therapeutic agent for allergy which realizes enhancement of therapeutic efficacy and improvement in side effects such as anaphylaxis in a method for treating allergy by allergen administration (hyposensitization therapy). n That is, the present invention provides the therapeutic agent for allergy comprising a liposome having on its surface an oligosaccharide capable of binding to a lectin derived from an antigen presenting cell and composed of 2 to 11 sugar residues, wherein an allergen is encapsulated in said liposome. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9877917-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2602771-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10987431-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9682042-B2 |
| priorityDate |
2006-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |